(Q36107266)

12 August 2017

1 reference

title

Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers (English)

1 reference

12 August 2017

0 references

0 references

0 references

Gerald D Silverberg

1

1 reference

12 August 2017

Martha Mayo

2

1 reference

12 August 2017

Thomas Saul

3

1 reference

12 August 2017

Joan Carvalho

4

1 reference

12 August 2017

Dawn McGuire

5

1 reference

12 August 2017

publication date

1 January 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

97-107

1 reference

Survival following a diagnosis of Alzheimer disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Amyloid inclusions in choroid plexus epithelial cells. A simple autopsy method to rapidly obtain information on the age of an unknown dead person

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Biondi ring tangles in the choroid plexus of Alzheimer's disease and normal aging brains: a quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Formation and absorption of cerebrospinal fluid in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Morphological alterations of the choroid plexus in late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Therapeutic strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

A cell biological perspective on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Implication of APP secretases in notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Immunotherapy with beta-amyloid for Alzheimer's disease: a new frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

Longitudinal stability of CSF tau levels in Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.97

21 January 2018

Identifiers

DOI

10.1586/14737175.4.1.97

1 reference

12 August 2017

1 reference